Bringing the Oncology Community Together

GSK and Novartis have struck a deal that will move all of GSK's oncology assets to Novartis, all of Novartis' non-flu-related vaccines to GSK, and will result in a joint consumer healthcare venture.
Employing nonphysician providers (NPPs) by physician practices has grown in the past 15 years
Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, gives an overview of the recent changes to the field of genetic testing.
E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses prostate cancer biopsies.
The FDA has approved the VEGFR-2 inhibitor ramucirumab as a treatment for patients with patients with unresectable gastric cancer or gastroesophageal junction adenocarcinoma, based on a significant extension in OS.
Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses an analysis of pacritinib for the treatment of myelofibrosis.
Joshua Richter, MD, hematologist/oncologist, multiple myeloma, John Theurer Cancer Center, discusses the use of novel oral anticoagulants for use in patients with hematologic malignancies.
In addition to the clinical skills lectures included in medical school curriculum, second-year medical students at Rutgers New Jersey Medical School in Newark, NJ, are also receiving a course in understanding the basics of billing and coding
Issue List
    Most Popular Right Now
    External Resources

    American Journal of Managed Care
    HCPLive
    PainLive
    Pharmacy Times
    Physicians' Education Resource
    Physician's Money Digest
    Specialty Pharmacy Times
    TargetedOnc
    OncLive Resources

    Archives
    Blogs
    OncLive TV
    Oncology Nurses
    Publications
    Specialties
    Web Exclusives


    About Us
    Advertise
    Advisory Board
    Contact Us
    Forgot Password
    Privacy Policy
    Terms & Conditions
    Intellisphere, LLC
    666 Plainsboro Road
    Building 300
    Plainsboro, NJ 08536
    P: 609-716-7777
    F: 609-716-4747

    Copyright OncLive 2006-2014
    Intellisphere, LLC. All Rights Reserved.